StockData
Universal Health Services Inc logo

Universal Health Services Inc (UHS) stock analysis

UHSNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 21/3041% below fair value
$193.84−2.93 (-1.49%)

Close on Nov 12, 2026Market cap $11.42BP/E 8.1Yield 0.41%

StockData Score

Prices as of Nov 11, 2026How the score works

Value6Growth2Performance6Health3Dividend4

Solid21 of 30 checks passed

Universal Health Services passes 21 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
2/6
Past performance
6/6
Financial health
3/6
Dividend
4/6

What stands out

  • Margin of safety over 20%

    The price is 40.9% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $196.77 is below our fair value estimate of $333.12.

  • Return on equity over 15%

    Return on equity was 19.8% over the last twelve months and averaged 15.7% over five years.

  • Return on capital over 10%

    Return on invested capital was 12.2%, above the 10% that usually covers the cost of capital.

What to watch

  • High debt

    Debt is 75.1% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.

  • Earnings growth not accelerating

    Net income grew 6.3% over the last twelve months, against a 5-year average of 9.5% a year.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.25; above 3 is the safe zone and below 1.8 the distress zone.

Valuation6/6
  • P/E below its 5-year median

    Universal Health Services's P/E of 8.2 is below its own 5-year median of 11.4.

  • P/E below the industry

    Universal Health Services's P/E of 8.2 is below the Health Services median of 23.9.

  • EV/EBITDA below its 5-year median

    Universal Health Services's EV/EBITDA of 6.5 is below its 5-year median of 8.0.

  • P/B below the industry

    Universal Health Services's price-to-book of 1.53 is below the Health Services median of 3.52.

  • Trading below fair value

    The share price of $196.77 is below our fair value estimate of $333.12.

  • Margin of safety over 20%

    The price is 40.9% below fair value, more than the 20% cushion we look for.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 36.2% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 6.3% over the last twelve months, against a 5-year average of 9.5% a year.

  • Growing faster than the industry

    Revenue grew 8.0% over the last twelve months; the Health Services median is 4.0%.

  • Guidance lowered

    Universal Health Services lowered its Year Ended December 31, 2026 Adjusted EPS – diluted outlook on Jul 28, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance6/6
  • Return on equity over 15%

    Return on equity was 19.8% over the last twelve months and averaged 15.7% over five years.

  • Return on capital over 10%

    Return on invested capital was 12.2%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Universal Health Services's return on equity of 19.8% is above the Health Services median of 4.6%.

  • Earnings grew over 5 years

    Net income grew 9.5% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 8.0% over the last twelve months, against a 5-year average of 6.7%.

  • Net margin above the industry

    Universal Health Services's net margin of 8.0% is above the Health Services median of -2.6%.

Financial health3/6
  • High debt

    Debt is 75.1% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 61.0% five years ago to 75.1%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 36.0% of total debt.

  • Interest well covered

    Operating income covers interest expense 11.3 times.

  • Short-term assets cover short-term debts

    Current assets are 1.37 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.25; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Universal Health Services paid dividends worth 0.4% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.4% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Universal Health Services yields 0.4%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 7 fiscal years.

  • Covered by earnings

    Dividends take 3.3% of net income.

  • Covered by free cash flow

    Dividends take 4.4% of free cash flow.

Scores of similar companies

Our estimate per share

$333.12

The share price is 41% below this estimate.

20%+ below
Near fair value
20%+ above
$196.77Price$333.12Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E17.6×11.4×23.9×$421.3240%
EV/EBITDA8.3×8.0×8.6×$277.8735%
P/B2.6×1.8×3.5×$340.6110%
Earnings power8.7% cost of equity––$221.8815%
Fair value$333.12100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 11.4
  • Health Services median 23.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$128.42M
Value traded per 1% price move
$87.56M

Downside

Medium risk

Typical loss in a bad month
18.3%
Volatility (annualized)
34%
Sharpe ratio, 1 year
-0.47
Beta to the S&P 500 (5Y)
0.77

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

11.5%−0.3 pts over 5 years

Net margin

8.6%+0.4 pts over 5 years

See a number that looks wrong?